miltefosine has been researched along with Blood Poisoning in 2 studies
miltefosine: hexadecyl phosphocholine derivative of cisplatin; did not substantially activate HIV long terminal repeat; less toxic than cisplatin
miltefosine : A phospholipid that is the hexadecyl monoester of phosphocholine.
Excerpt | Relevance | Reference |
---|---|---|
"Miltefosine was orally administered at doses of 15 and 30 mg/kg/day after, at the time of, and before bacterial challenge for 3-5 days." | 1.35 | In vitro and in vivo activity of miltefosine against penicillin-sensitive and -resistant Streptococcus pneumoniae strains. ( Del Prado, G; Gracia, M; Huelves, L; Ponte, C; Rodríguez-Cerrato, V, 2008) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Huelves, L | 1 |
Del Prado, G | 1 |
Gracia, M | 1 |
Rodríguez-Cerrato, V | 1 |
Ponte, C | 1 |
Ferguson, LM | 1 |
Dreisbach, AW | 1 |
Csongrádi, E | 1 |
Juncos, LA | 1 |
Fulop, T | 1 |
2 other studies available for miltefosine and Blood Poisoning
Article | Year |
---|---|
In vitro and in vivo activity of miltefosine against penicillin-sensitive and -resistant Streptococcus pneumoniae strains.
Topics: Animals; Anti-Bacterial Agents; Bacteriological Techniques; Dose-Response Relationship, Drug; Mice; | 2008 |
Recurring extracorporeal circuit clotting during continuous renal replacement therapy in fungal sepsis: successful treatment with argatroban.
Topics: Antifungal Agents; Antithrombins; Arginine; Blood Coagulation; Coronary Artery Bypass; Humans; Male; | 2013 |